QuVa Pharma, Inc. Recall: fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250
QuVa Pharma, Inc. Recall: fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: QuVa Pharma, Inc.; Product: fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free, Rx, QuVA Pharma 1075 West Park
| Recalling firm | QuVa Pharma, Inc. |
|---|---|
| Product | fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1444-05 |
| Reason for recall | Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide. |
| Recall initiated | 20191112 |
| Recall number | D-0567-2020 |
| Category | drug |
| State | TX |
| Country | United States |
$29/mo
Try RecallGuard →